[Subjective changes with delta 9 trans-tetrahydrocannabinol in cannabis naive subjects].
D000284:Administration, Oral; D000328:Adult; D001007:Anxiety / Q000139:chemically induced; D001288:Attention / Q000187:drug effects; D001519:Behavior / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002188:Cannabis / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003861:Depersonalization / Q000139:chemically induced; D003863:Depression / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D013759:Dronabinol / Q000008:administration & dosage / Q000494:pharmacology*; D005059:Euphoria / Q000187:drug effects; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008568:Memory / Q000187:drug effects; D010919:Placebos; D011674:Pulse / Q000187:drug effects; D013997:Time Factors
D010919:Placebos; D013759:Dronabinol
Subjektive Veränderungen unter (minus) delta 9-trans-Tetrahydrocannabinol bei cannabisnaiven Probanden